AGO1 and ovarian carcinoma: In our study, we reveal the downstream mechanism of miR‐148a‐3p in ovarian cancer is related to the negative regulation of AGO1 through bioinformatics analysis and dual luciferin report experiment, which expands the functional roles of miRNA‐148a‐3p in ovarian cancer.